These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9099206)

  • 21. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
    Wilson SH; Best PJ; Lerman LO; Holmes DR; Richardson DM; Lerman A
    Cardiovasc Res; 1999 Dec; 44(3):601-7. PubMed ID: 10690293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular signaling by 8-epi-prostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries.
    Mohler ER; Franklin MT; Adam LP
    Biochem Biophys Res Commun; 1996 Aug; 225(3):915-23. PubMed ID: 8780711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-nociceptor sensitization by isoprostanes is cyclooxygenase dependent.
    Junger H; Sorkin LS
    Brain Res; 2000 Jun; 867(1-2):255-8. PubMed ID: 10837823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary artery.
    Cracowski JL; Devillier P; Chavanon O; Sietchiping-Nzepa FA; Stanke-Labesque F; Bessard G
    Life Sci; 2001 Apr; 68(21):2405-13. PubMed ID: 11350011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells.
    Fukunaga M; Makita N; Roberts LJ; Morrow JD; Takahashi K; Badr KF
    Am J Physiol; 1993 Jun; 264(6 Pt 1):C1619-24. PubMed ID: 8333509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
    Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
    J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoprostanes and the kidney.
    Badr KF; Abi-Antoun TE
    Antioxid Redox Signal; 2005; 7(1-2):236-43. PubMed ID: 15650411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body.
    Awe SO; Opere CA; Harris LC; Uketui AJ; Ohia SE
    Neurochem Res; 2000 Apr; 25(4):491-6. PubMed ID: 10823581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist.
    Morrow JD; Minton TA; Roberts LJ
    Prostaglandins; 1992 Aug; 44(2):155-63. PubMed ID: 1438879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; NĂ¼sing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nonenzymatically generated prostanoid, 8-iso-PGF2 alpha, in pulmonary oxygen toxicity.
    Vacchiano CA; Tempel GE
    J Appl Physiol (1985); 1994 Dec; 77(6):2912-7. PubMed ID: 7896640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
    Daray FM; Minvielle AI; Puppo S; Rothlin RP
    Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permissive role of prostanoids in acetylcholine-induced cerebral vasoconstriction.
    Armstead WM; Mirro R; Busija DW; Leffler CW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1012-9. PubMed ID: 2532248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.
    Chen JX; O'Mara PW; Poole SD; Brown N; Ehinger NJ; Slaughter JC; Paria BC; Aschner JL; Reese J
    Pediatr Res; 2012 Aug; 72(2):122-8. PubMed ID: 22565502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors.
    Elmhurst JL; Betti PA; Rangachari PK
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1198-205. PubMed ID: 9316826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons.
    Evans AR; Junger H; Southall MD; Nicol GD; Sorkin LS; Broome JT; Bailey TW; Vasko MR
    J Pharmacol Exp Ther; 2000 Jun; 293(3):912-20. PubMed ID: 10869392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine dilates pial arterioles of newborn pigs through prostanoid production.
    Mirro R; Busija DW; Armstead WM; Leffler CW
    Am J Physiol; 1988 Jun; 254(6 Pt 2):H1023-6. PubMed ID: 3381890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells.
    Yura T; Fukunaga M; Khan R; Nassar GN; Badr KF; Montero A
    Kidney Int; 1999 Aug; 56(2):471-8. PubMed ID: 10432385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilatory and electrophysiological actions of 8-iso-prostaglandin E2 in porcine coronary artery.
    Zhang Y; Tazzeo T; Hirota S; Janssen LJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1054-60. PubMed ID: 12626646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F2-isoprostane receptors on hepatic stellate cells.
    Gardi C; Arezzini B; Monaco B; De Montis MG; Vecchio D; Comporti M
    Lab Invest; 2008 Feb; 88(2):124-31. PubMed ID: 18158556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.